148 related articles for article (PubMed ID: 18667098)
21. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
22. Differences in beta-amyloid (beta/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease.
Armstrong RA
Neurosci Lett; 1994 Mar; 169(1-2):133-6. PubMed ID: 8047269
[TBL] [Abstract][Full Text] [Related]
23. Hippocampal shape analysis in Alzheimer's disease: a population-based study.
Scher AI; Xu Y; Korf ES; White LR; Scheltens P; Toga AW; Thompson PM; Hartley SW; Witter MP; Valentino DJ; Launer LJ
Neuroimage; 2007 May; 36(1):8-18. PubMed ID: 17434756
[TBL] [Abstract][Full Text] [Related]
24. Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease.
Murphy GM; Eng LF; Ellis WG; Perry G; Meissner LC; Tinklenberg JR
Brain Res; 1990 Dec; 537(1-2):102-8. PubMed ID: 1707726
[TBL] [Abstract][Full Text] [Related]
25. [Structural cerebral changes in subjects with mild cognitive impairment].
Pantel J; Hüger DR; Kratz B; Minnemann E; Martin M; Schad LR; Essig M; Schröder J
Nervenarzt; 2002 Sep; 73(9):845-50. PubMed ID: 12215875
[TBL] [Abstract][Full Text] [Related]
26. More atrophy of deep gray matter structures in frontotemporal dementia compared to Alzheimer's disease.
Möller C; Dieleman N; van der Flier WM; Versteeg A; Pijnenburg Y; Scheltens P; Barkhof F; Vrenken H
J Alzheimers Dis; 2015; 44(2):635-47. PubMed ID: 25322925
[TBL] [Abstract][Full Text] [Related]
27. Small planum temporale volume in Down's syndrome: a volumetric MRI study.
Frangou S; Aylward E; Warren A; Sharma T; Barta P; Pearlson G
Am J Psychiatry; 1997 Oct; 154(10):1424-9. PubMed ID: 9326826
[TBL] [Abstract][Full Text] [Related]
28. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.
Arena A; Iyer AM; Milenkovic I; Kovacs GG; Ferrer I; Perluigi M; Aronica E
Curr Alzheimer Res; 2017; 14(12):1305-1317. PubMed ID: 28720071
[TBL] [Abstract][Full Text] [Related]
29. Discriminative analysis of early-stage Alzheimer's disease and normal aging with automatic segmentation technique in subcortical gray matter structures: a multicenter in vivo MRI volumetric and DTI study.
Li YD; He HJ; Dong HB; Feng XY; Xie GM; Zhang LJ
Acta Radiol; 2013 Dec; 54(10):1191-200. PubMed ID: 23878359
[TBL] [Abstract][Full Text] [Related]
30. Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia.
Sabbagh MN; Chen K; Rogers J; Fleisher AS; Liebsack C; Bandy D; Belden C; Protas H; Thiyyagura P; Liu X; Roontiva A; Luo J; Jacobson S; Malek-Ahmadi M; Powell J; Reiman EM
Alzheimers Dement; 2015 Aug; 11(8):994-1004. PubMed ID: 25849033
[TBL] [Abstract][Full Text] [Related]
31. [Quantitative magnetic resonance tomography in diagnosis of Alzheimer dementia].
Schönknecht P; Pantel J; Schröder J
Z Gerontol Geriatr; 2001 Apr; 34(2):101-7. PubMed ID: 11393001
[TBL] [Abstract][Full Text] [Related]
32. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
[TBL] [Abstract][Full Text] [Related]
33. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
[TBL] [Abstract][Full Text] [Related]
34. MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease.
Almeida OP; Burton EJ; McKeith I; Gholkar A; Burn D; O'Brien JT
Dement Geriatr Cogn Disord; 2003; 16(2):57-63. PubMed ID: 12784028
[TBL] [Abstract][Full Text] [Related]
35. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.
McClure RK; Phillips I; Jazayerli R; Barnett A; Coppola R; Weinberger DR
Psychiatry Res; 2006 Dec; 148(2-3):121-32. PubMed ID: 17097276
[TBL] [Abstract][Full Text] [Related]
36. Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer's disease, and vascular dementia.
Barber R; McKeith I; Ballard C; O'Brien J
J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):406-7. PubMed ID: 11861709
[TBL] [Abstract][Full Text] [Related]
37. Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations.
Lee GJ; Lu PH; Medina LD; Rodriguez-Agudelo Y; Melchor S; Coppola G; Braskie MN; Hua X; Apostolova LG; Leow AD; Thompson PM; Ringman JM
J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):154-62. PubMed ID: 23085935
[TBL] [Abstract][Full Text] [Related]
38. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.
Risacher SL; Saykin AJ; West JD; Shen L; Firpi HA; McDonald BC;
Curr Alzheimer Res; 2009 Aug; 6(4):347-61. PubMed ID: 19689234
[TBL] [Abstract][Full Text] [Related]
39. Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry.
Frisoni GB; Testa C; Zorzan A; Sabattoli F; Beltramello A; Soininen H; Laakso MP
J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):657-64. PubMed ID: 12438466
[TBL] [Abstract][Full Text] [Related]
40. Sex differences in grey matter atrophy patterns among AD and aMCI patients: results from ADNI.
Skup M; Zhu H; Wang Y; Giovanello KS; Lin JA; Shen D; Shi F; Gao W; Lin W; Fan Y; Zhang H;
Neuroimage; 2011 Jun; 56(3):890-906. PubMed ID: 21356315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
